Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine

Abstract In many parts of the African Sahel and sub-Sahel, where malaria remains a major cause of mortality and morbidity, transmission of the infection is highly seasonal. Seasonal malaria chemoprevention (SMC), which involves administration of a full course of malaria treatment to young children a...

Full description

Bibliographic Details
Main Authors: Brian Greenwood, Alassane Dicko, Issaka Sagara, Issaka Zongo, Halidou Tinto, Matthew Cairns, Irene Kuepfer, Paul Milligan, Jean-Bosco Ouedraogo, Ogobara Doumbo, Daniel Chandramohan
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-017-1841-9
id doaj-b625908b55744d9b9202da0cf15006de
record_format Article
spelling doaj-b625908b55744d9b9202da0cf15006de2020-11-25T00:31:50ZengBMCMalaria Journal1475-28752017-05-011611510.1186/s12936-017-1841-9Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccineBrian Greenwood0Alassane Dicko1Issaka Sagara2Issaka Zongo3Halidou Tinto4Matthew Cairns5Irene Kuepfer6Paul Milligan7Jean-Bosco Ouedraogo8Ogobara Doumbo9Daniel Chandramohan10Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineMalaria Research and Training Centre, University of Sciences Techniques and TechnologiesMalaria Research and Training Centre, University of Sciences Techniques and TechnologiesInstitut de Recherche en Sciences de la SantéInstitut de Recherche en Sciences de la SantéFaculty of Epidemiology and Public Health, London School of Hygiene and Tropical MedicineFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineFaculty of Epidemiology and Public Health, London School of Hygiene and Tropical MedicineInstitut de Recherche en Sciences de la SantéMalaria Research and Training Centre, University of Sciences Techniques and TechnologiesFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineAbstract In many parts of the African Sahel and sub-Sahel, where malaria remains a major cause of mortality and morbidity, transmission of the infection is highly seasonal. Seasonal malaria chemoprevention (SMC), which involves administration of a full course of malaria treatment to young children at monthly intervals during the high transmission season, is proving to be an effective malaria control measure in these areas. However, SMC does not provide complete protection and it is demanding to deliver for both families and healthcare givers. Furthermore, there is a risk of the emergence in the future of resistance to the drugs, sulfadoxine–pyrimethamine and amodiaquine, that are currently being used for SMC. Substantial progress has been made in the development of malaria vaccines during the past decade and one malaria vaccine, RTS,S/AS01, has received a positive opinion from the European Medicines Authority and will soon be deployed in large-scale, pilot implementation projects in sub-Saharan Africa. A characteristic feature of this vaccine, and potentially of some of the other malaria vaccines under development, is that they provide a high level of efficacy during the period immediately after vaccination, but that this wanes rapidly, perhaps because it is difficult to develop effective immunological memory to malaria antigens in subjects exposed previously to malaria infection. A potentially effective way of using malaria vaccines with high initial efficacy but which provide only a short period of protection could be annual, mass vaccination campaigns shortly before each malaria transmission season in areas where malaria transmission is confined largely to a few months of the year.http://link.springer.com/article/10.1186/s12936-017-1841-9Seasonal malaria transmissionSeasonal malaria chemopreventionSeasonal malaria vaccination
collection DOAJ
language English
format Article
sources DOAJ
author Brian Greenwood
Alassane Dicko
Issaka Sagara
Issaka Zongo
Halidou Tinto
Matthew Cairns
Irene Kuepfer
Paul Milligan
Jean-Bosco Ouedraogo
Ogobara Doumbo
Daniel Chandramohan
spellingShingle Brian Greenwood
Alassane Dicko
Issaka Sagara
Issaka Zongo
Halidou Tinto
Matthew Cairns
Irene Kuepfer
Paul Milligan
Jean-Bosco Ouedraogo
Ogobara Doumbo
Daniel Chandramohan
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
Malaria Journal
Seasonal malaria transmission
Seasonal malaria chemoprevention
Seasonal malaria vaccination
author_facet Brian Greenwood
Alassane Dicko
Issaka Sagara
Issaka Zongo
Halidou Tinto
Matthew Cairns
Irene Kuepfer
Paul Milligan
Jean-Bosco Ouedraogo
Ogobara Doumbo
Daniel Chandramohan
author_sort Brian Greenwood
title Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
title_short Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
title_full Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
title_fullStr Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
title_full_unstemmed Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
title_sort seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
publisher BMC
series Malaria Journal
issn 1475-2875
publishDate 2017-05-01
description Abstract In many parts of the African Sahel and sub-Sahel, where malaria remains a major cause of mortality and morbidity, transmission of the infection is highly seasonal. Seasonal malaria chemoprevention (SMC), which involves administration of a full course of malaria treatment to young children at monthly intervals during the high transmission season, is proving to be an effective malaria control measure in these areas. However, SMC does not provide complete protection and it is demanding to deliver for both families and healthcare givers. Furthermore, there is a risk of the emergence in the future of resistance to the drugs, sulfadoxine–pyrimethamine and amodiaquine, that are currently being used for SMC. Substantial progress has been made in the development of malaria vaccines during the past decade and one malaria vaccine, RTS,S/AS01, has received a positive opinion from the European Medicines Authority and will soon be deployed in large-scale, pilot implementation projects in sub-Saharan Africa. A characteristic feature of this vaccine, and potentially of some of the other malaria vaccines under development, is that they provide a high level of efficacy during the period immediately after vaccination, but that this wanes rapidly, perhaps because it is difficult to develop effective immunological memory to malaria antigens in subjects exposed previously to malaria infection. A potentially effective way of using malaria vaccines with high initial efficacy but which provide only a short period of protection could be annual, mass vaccination campaigns shortly before each malaria transmission season in areas where malaria transmission is confined largely to a few months of the year.
topic Seasonal malaria transmission
Seasonal malaria chemoprevention
Seasonal malaria vaccination
url http://link.springer.com/article/10.1186/s12936-017-1841-9
work_keys_str_mv AT briangreenwood seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT alassanedicko seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT issakasagara seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT issakazongo seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT halidoutinto seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT matthewcairns seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT irenekuepfer seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT paulmilligan seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT jeanboscoouedraogo seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT ogobaradoumbo seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
AT danielchandramohan seasonalvaccinationagainstmalariaapotentialuseforanimperfectmalariavaccine
_version_ 1725322105580421120